CA Stock MarketDetailed Quotes

LXG.H Lexagene Holdings Inc

Watchlist

0.105
0.0000.00%

15min DelayTrading Nov 13 09:30 ET

14.77MMarket Cap-1296P/E (TTM)

Lexagene Holdings Inc Key Stats

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Nov 30, 2022

(Q2)Aug 31, 2022

(Q1)May 31, 2022

(FY)Feb 28, 2022

(Q4)Feb 28, 2022

(Q3)Nov 30, 2021

(Q2)Aug 31, 2021

(Q1)May 31, 2021

(FY)Feb 28, 2021

(Q4)Feb 28, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

32.10%-1.63M

39.23%-1.64M

33.82%-1.8M

-6.65%-9.65M

13.73%-1.84M

28.51%-2.4M

-45.96%-2.69M

-58.54%-2.72M

-67.07%-9.04M

-95.22%-2.13M

Net income from continuing operations

37.80%-1.68M

27.70%-2.1M

22.15%-2.11M

-7.37%-10.62M

2.31%-2.3M

9.49%-2.7M

-37.88%-2.91M

-10.95%-2.71M

-31.89%-9.89M

-40.36%-2.36M

Depreciation and amortization

1.21%127.28K

6.13%121.86K

1.20%133.92K

-1.53%513.86K

2.49%140.95K

-0.54%125.75K

-10.78%114.82K

2.44%132.33K

2.86%521.84K

-25.80%137.52K

Remuneration paid in stock

-41.11%138.53K

-65.33%168.45K

-46.94%143.06K

-10.58%956.22K

-115.95%-34.49K

-49.23%235.23K

283.50%485.89K

2.50%269.6K

-32.75%1.07M

-40.86%216.29K

Other non cashItems

10.39%17.87K

-27.56%12.22K

-18.80%15.1K

267.11%52.32K

100.69%664

-20.60%16.19K

-36.52%16.87K

6.32%18.6K

-130.84%-31.31K

-222.29%-95.76K

Change In working capital

-197.56%-234.87K

140.02%161.94K

105.20%22.04K

23.08%-548.71K

1,312.52%358.81K

92.00%-78.93K

-2,708.45%-404.64K

-233.80%-423.95K

-529.31%-713.38K

26.87%-29.59K

-Change in receivables

-67.83%-26.86K

-98.78%189

-286.88%-10.59K

172.59%29.71K

167.08%24.54K

-1,047.38%-16.01K

2,232.74%15.51K

355.25%5.67K

-1,195.50%-40.93K

-1,058.02%-36.58K

-Change in inventory

-79.11%47.18K

82.18%-64.83K

83.93%-31.22K

69.01%-330.29K

100.32%2.1K

153.88%225.8K

---363.87K

---194.32K

---1.07M

---646.82K

-Change in prepaid assets

66.97%-68.98K

10.95%99.33K

7,265.64%74.67K

47.80%-55.21K

13.05%65.12K

-35.96%-208.81K

260.99%89.53K

-102.27%-1.04K

-1,217.87%-105.76K

220.63%57.6K

-Change in payables and accrued expense

-194.72%-186.21K

205.33%79.16K

95.39%-10.81K

-129.01%-144.83K

-61.80%227.76K

84.67%-63.18K

-279.23%-75.15K

-185.74%-234.26K

588.60%499.23K

5,609.70%596.21K

-Change in other current assets

--0

----

---48.09K

--39.3K

---16.74K

----

--0

Cash from discontinued investing activities

Operating cash flow

32.10%-1.63M

39.23%-1.64M

33.82%-1.8M

-6.65%-9.65M

13.72%-1.84M

28.51%-2.4M

-46.36%-2.69M

-58.08%-2.72M

-67.07%-9.04M

-95.21%-2.13M

Investing cash flow

Cash flow from continuing investing activities

73.78%-17.86K

69.62%-5.73K

-358.10%-12.14K

-6.63%-68.13K

-119.17%-46.63K

Net PPE purchase and sale

--0

73.78%-17.86K

--0

69.62%-5.73K

--0

-358.10%-12.14K

-6.63%-68.13K

-119.17%-46.63K

Cash from discontinued investing activities

Investing cash flow

--0

73.78%-17.86K

--0

69.62%-5.73K

--0

-358.10%-12.14K

-6.63%-68.13K

-119.17%-46.63K

Financing cash flow

Cash flow from continuing financing activities

1,175.07%998.71K

-18.44%-84.47K

-39.85%-104.75K

-70.30%4.6M

75.60%4.83M

-101.02%-92.9K

-102.57%-71.32K

-108.49%-74.9K

90.09%15.48M

123.87%2.75M

Net issuance payments of debt

891.64%735.41K

9.88%-89.3K

-5.71%-104.75K

-37.83%-400.14K

-6,342.64%-109.06K

1.04%-92.9K

0.00%-99.09K

-0.00%-99.09K

25.36%-290.31K

--1.75K

Net common stock issuance

----

-45.97%4.94M

----

41.50%9.15M

-26.92%-45.69K

Proceeds from stock option exercised by employees

--263.3K

--0

-99.21%51.96K

--0

-99.03%27.77K

-97.53%24.19K

220.56%6.62M

69.04%2.8M

Net other financing activities

--0

----

Cash from discontinued financing activities

Financing cash flow

1,175.07%998.71K

-18.44%-84.47K

-39.85%-104.75K

-70.30%4.6M

75.60%4.83M

-101.02%-92.9K

-102.57%-71.32K

-108.49%-74.9K

90.09%15.48M

123.87%2.75M

Net cash flow

Beginning cash position

-74.19%1.09M

-60.59%2.82M

-50.93%4.72M

202.12%9.62M

-81.42%1.72M

30.14%4.22M

209.34%7.16M

202.12%9.62M

374.80%3.19M

225.02%9.23M

Current changes in cash

74.75%-630.83K

37.74%-1.72M

32.13%-1.9M

-179.66%-5.07M

418.83%3M

-143.91%-2.5M

-398.01%-2.77M

-236.30%-2.8M

138.85%6.36M

51.06%577.83K

Effect of exchange rate changes

177.71%5.56K

94.13%-10.12K

-99.89%360

120.32%167.05K

105.03%9.32K

-102.40%-7.15K

-13,094.95%-172.31K

987.97%337.19K

150.76%75.82K

-396.18%-185.33K

End cash Position

-72.94%464.13K

-74.19%1.09M

-60.59%2.82M

-50.93%4.72M

-81.42%1.72M

30.14%4.22M

209.34%7.16M

202.12%9.62M

Free cash from

32.27%-1.63M

39.23%-1.64M

34.11%-1.8M

-6.05%-9.66M

15.57%-1.84M

28.74%-2.41M

-46.36%-2.69M

-58.54%-2.73M

-66.37%-9.11M

-156.74%-2.18M

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Nov 30, 2022	(Q2)Aug 31, 2022	(Q1)May 31, 2022	(FY)Feb 28, 2022	(Q4)Feb 28, 2022	(Q3)Nov 30, 2021	(Q2)Aug 31, 2021	(Q1)May 31, 2021	(FY)Feb 28, 2021	(Q4)Feb 28, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	32.10%-1.63M	39.23%-1.64M	33.82%-1.8M	-6.65%-9.65M	13.73%-1.84M	28.51%-2.4M	-45.96%-2.69M	-58.54%-2.72M	-67.07%-9.04M	-95.22%-2.13M
Net income from continuing operations	37.80%-1.68M	27.70%-2.1M	22.15%-2.11M	-7.37%-10.62M	2.31%-2.3M	9.49%-2.7M	-37.88%-2.91M	-10.95%-2.71M	-31.89%-9.89M	-40.36%-2.36M
Depreciation and amortization	1.21%127.28K	6.13%121.86K	1.20%133.92K	-1.53%513.86K	2.49%140.95K	-0.54%125.75K	-10.78%114.82K	2.44%132.33K	2.86%521.84K	-25.80%137.52K
Remuneration paid in stock	-41.11%138.53K	-65.33%168.45K	-46.94%143.06K	-10.58%956.22K	-115.95%-34.49K	-49.23%235.23K	283.50%485.89K	2.50%269.6K	-32.75%1.07M	-40.86%216.29K
Other non cashItems	10.39%17.87K	-27.56%12.22K	-18.80%15.1K	267.11%52.32K	100.69%664	-20.60%16.19K	-36.52%16.87K	6.32%18.6K	-130.84%-31.31K	-222.29%-95.76K
Change In working capital	-197.56%-234.87K	140.02%161.94K	105.20%22.04K	23.08%-548.71K	1,312.52%358.81K	92.00%-78.93K	-2,708.45%-404.64K	-233.80%-423.95K	-529.31%-713.38K	26.87%-29.59K
-Change in receivables	-67.83%-26.86K	-98.78%189	-286.88%-10.59K	172.59%29.71K	167.08%24.54K	-1,047.38%-16.01K	2,232.74%15.51K	355.25%5.67K	-1,195.50%-40.93K	-1,058.02%-36.58K
-Change in inventory	-79.11%47.18K	82.18%-64.83K	83.93%-31.22K	69.01%-330.29K	100.32%2.1K	153.88%225.8K	---363.87K	---194.32K	---1.07M	---646.82K
-Change in prepaid assets	66.97%-68.98K	10.95%99.33K	7,265.64%74.67K	47.80%-55.21K	13.05%65.12K	-35.96%-208.81K	260.99%89.53K	-102.27%-1.04K	-1,217.87%-105.76K	220.63%57.6K
-Change in payables and accrued expense	-194.72%-186.21K	205.33%79.16K	95.39%-10.81K	-129.01%-144.83K	-61.80%227.76K	84.67%-63.18K	-279.23%-75.15K	-185.74%-234.26K	588.60%499.23K	5,609.70%596.21K
-Change in other current assets	--0	----	----	---48.09K	--39.3K	---16.74K	----	----	--0	--0
Cash from discontinued investing activities
Operating cash flow	32.10%-1.63M	39.23%-1.64M	33.82%-1.8M	-6.65%-9.65M	13.72%-1.84M	28.51%-2.4M	-46.36%-2.69M	-58.08%-2.72M	-67.07%-9.04M	-95.21%-2.13M
Investing cash flow
Cash flow from continuing investing activities	0	0	0	73.78%-17.86K	0	69.62%-5.73K	0	-358.10%-12.14K	-6.63%-68.13K	-119.17%-46.63K
Net PPE purchase and sale	--0	--0	--0	73.78%-17.86K	--0	69.62%-5.73K	--0	-358.10%-12.14K	-6.63%-68.13K	-119.17%-46.63K
Cash from discontinued investing activities
Investing cash flow	--0	--0	--0	73.78%-17.86K	--0	69.62%-5.73K	--0	-358.10%-12.14K	-6.63%-68.13K	-119.17%-46.63K
Financing cash flow
Cash flow from continuing financing activities	1,175.07%998.71K	-18.44%-84.47K	-39.85%-104.75K	-70.30%4.6M	75.60%4.83M	-101.02%-92.9K	-102.57%-71.32K	-108.49%-74.9K	90.09%15.48M	123.87%2.75M
Net issuance payments of debt	891.64%735.41K	9.88%-89.3K	-5.71%-104.75K	-37.83%-400.14K	-6,342.64%-109.06K	1.04%-92.9K	0.00%-99.09K	-0.00%-99.09K	25.36%-290.31K	--1.75K
Net common stock issuance	----	----	----	-45.97%4.94M	----	----	----	----	41.50%9.15M	-26.92%-45.69K
Proceeds from stock option exercised by employees	--263.3K	--0	--0	-99.21%51.96K	--0	--0	-99.03%27.77K	-97.53%24.19K	220.56%6.62M	69.04%2.8M
Net other financing activities	--0	----	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	1,175.07%998.71K	-18.44%-84.47K	-39.85%-104.75K	-70.30%4.6M	75.60%4.83M	-101.02%-92.9K	-102.57%-71.32K	-108.49%-74.9K	90.09%15.48M	123.87%2.75M
Net cash flow
Beginning cash position	-74.19%1.09M	-60.59%2.82M	-50.93%4.72M	202.12%9.62M	-81.42%1.72M	30.14%4.22M	209.34%7.16M	202.12%9.62M	374.80%3.19M	225.02%9.23M
Current changes in cash	74.75%-630.83K	37.74%-1.72M	32.13%-1.9M	-179.66%-5.07M	418.83%3M	-143.91%-2.5M	-398.01%-2.77M	-236.30%-2.8M	138.85%6.36M	51.06%577.83K
Effect of exchange rate changes	177.71%5.56K	94.13%-10.12K	-99.89%360	120.32%167.05K	105.03%9.32K	-102.40%-7.15K	-13,094.95%-172.31K	987.97%337.19K	150.76%75.82K	-396.18%-185.33K
End cash Position	-72.94%464.13K	-74.19%1.09M	-60.59%2.82M	-50.93%4.72M	-50.93%4.72M	-81.42%1.72M	30.14%4.22M	209.34%7.16M	202.12%9.62M	202.12%9.62M
Free cash from	32.27%-1.63M	39.23%-1.64M	34.11%-1.8M	-6.05%-9.66M	15.57%-1.84M	28.74%-2.41M	-46.36%-2.69M	-58.54%-2.73M	-66.37%-9.11M	-156.74%-2.18M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

LXG.H Lexagene Holdings Inc

Lexagene Holdings Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow